First and Second Applications

EKFS wants to use this funding programme to support young scientists in the field of medicine.
First Applications: Entry to scientific self-reliance

EKFS wants to use this funding programme to support young scientists in the field of medicine whose scholastic work until now gives reason to expect a successful career in science, although in terms of raising funds for their research they are still just starting out. Applications can be submitted at any time.

Supporting young applicants with a passion for research on the way to becoming scientifically independent has always been a focus of the Else Kröner-Fresenius-Stiftung. First applications can be submitted by postdoctoral physicians, as well as life scientists engaged in medical research. Application can be made for the human and material resources necessary towards implementing the project. Sums of money to fund one’s own position are ruled out.


Addressees Eligible to Apply
To apply, the applicant institution must make a substantial contribution of its own: approx. 1/3 of total project expenditure must be provided in the form of human and material resources from the institutional funding.

Anne Asschenfeldt
Scientific Funding: ongoing project funding and fellowships
Portrait Anne Asschenfeldt
Default Image Contact module

In addition, first original publications as lead author should be available.

As a general rule, the applicants will have continued their scientific work after their PhD, during their time as a postdoctoral fellow, or alongside their further medical training. The acquisition of intramural funding or smaller external sub-project funding (e.g. as co-applicant) shall not pose an obstacle to the application.

Scientists who have acquired more than one funded project as project managers in peer-reviewed procedures from the DFG, BMBF, Krebshilfe, EU, Else Kröner-Fresenius Foundation among others, shall, however, not be eligible to make an application in this procedure.

 

Call of Proposals: Medical and Scientific Funding

Notes: Call for Proposals Publication Prize
The Else Kröner-Fresenius-Stiftung awards three publication prizes for younger scientists for outstanding publications that have emerged from the Foundation's support. The next publication prizes will probably be awarded in 2021 for publications from 2020.

Detailed information can be found here.

Downloads

Project Funding for First-Time Applicants
Information for First and Second Applicants (only available in German)
Sample (only available in German)
Declaration of Consent of the Hospital Director
Terms and Conditionspdf / 138.15 KB
of Approval (in German)

Overview of first and second applications running since 2019

Konrad Aden, University Hospital Schleswig-Holstein

First application "Atg16l1-mediated autophagy as a critical instructor of DNA damage responses in intestinal inflammation and carcinogenesis" (2019)

Here 
you can get further information.

A brief description can be found on our website in the menu Currently Funded Projects.

Fabio Bernadoni, Technical University of Dresden

First application "A dimensional psychiatry approach to eating disorders using machine learning techniques on structural and functional neuroimaging data from multicenter studies" (2019) 

A brief description can be found on our website in the menu Currently Funded Projects.

Florian Blachutzik, University Hospital Gießen

First application "Comparison of coronary lithoplasty and rotablation for interventional treatment of severely calcified coronary lesions - ROTASHOCK study" (2019)

Here you can get further information.

A brief description can be feound on our website in the menu Currently Funded Projects.

Veit R. Buchholz, Technical University of Munich

First application "Dissecting the Induction of Inflationary CD8+ T Cell Memory on the Single-Cell Level" (2019)



 

Sebastian Cremer, University Hospital Frankfurt

First application "Role of LncRNAs in inflammatory remodeling in ischemic heart failure" (2019)

Lukas Cyganek, University Hospital Göttingen

First application "Preclinical evaluation of CRISPR/Cas-based gene therapy in the human heart muscle" (2019)

Here 
you can get further information.

A brief description can be found on our website in the menu Currently Funded Projects.

Anna Eichler, University Hospital Erlangen

First application " `This one drink!?´ The invisible developmental consequences of intrauterine alcohol exposure: A longitudinal multi-level study in childhood and adolescence based on a meconium ethanol metabolite" (2019)

A brief description can be found on our website in the menu Currently Funded Projects.

Andreas Forstner, University Hospital Marburg

First application "Social Phobia Research: Understanding phenotypic dimensions and the genetic architecture of social anxiety disorder" (2019)

Here you can get further information.


A brief description can be found on our website in the menu Currently Funded Projects.

Stefan Hartmann, University Hospital Würzburg

First application "Immune escape mechanisms in head and neck carcinomas - significance of the HGF/Met signalling pathway" (2019)

Here you can get further information.


A brief description can be found on our website in the menu Currently Funded Projects.

Jan Hirschmann, University Hospital Düsseldorf

First application "The Neural Networks underlying Corticobasal Syndrome revealed by Magnetoencephalograph" (2019)

A brief description can be found on our website in the menu Currently Funded Projects.

Johannes Jung, University Hospital Freiburg

First application "The role of CBX7 in pathogenesis and treatment of Multiple Myeloma" (2019)

 

Selina Keppler, Technical University of Munich

First application "Analysing the interplay of aberrant cytokine-producing B cells, T cells and plasma cells during colitis development" (2019)

A brief description can be found on our website in the menu Currently Funded Projects.

Andrea Kliewer, University Hospital Jena

First application "GRK5 in the development of opiate dependence" (2019)

Here you can get further information.

A brief description can be found on our website in the menu Currently Funded Projects.
 

Natalie Köhler, University Hospital Freiburg

First application "The impact of microRNA-146a on the development of immune related adverse events during immune checkpoint inhibitor therapy" (2019)

Esther Kühn, University Hospital Magdeburg

First application "Topography and plasticity of cortical microstructure in ALS characterized with Hilde of 7 Tesla MRI" (2019)

Here you can get further information.

A brief description can be found on our website in the menu Currently Funded Projects.
 

Maximilian Lenz, University Hospital Freiburg

First application "Investigation of synaptic properties of entorhino-hippocampal projection at the single cell level" (2019)

Here you can get further information.

A brief description can be found on our website in the menu Currently Funded Projects.

Carolin Lerchenmüller, University Hospital Heidelberg

First application "The role of cardiac CITED4 in age-related myocardial changes" (2019)

A brief description can be found on our website in the menu Currently Funded Projects.

Simone Mader, University Hospital Munich

First application "Beyond Aquaporin and MOG - Novel brain reactive antibodies and B cell responses in Neuromyelitis optica spectrum disorders" (2019)

Here you can get further information.


A brief description can be found on our website in the menu Currently Funded Projects.

Philipp Mergenthaler, University Medicine Berlin Charité Campus Mitte

First application "Investigating life and death consequences of dynamic metabolism]activated programmed cell death]regulating protein complexes in acute neurodegeneration" (2019)





 

Alessandro Ori, Leibniz Institute on Aging – Fritz Lipmann Institute

First application "Identification and functional validation of the proteome changes influencing the decline of the intestinal epithelium in aging" (2019)

Here you can get further information.


A brief description can be found on our website in the menu Currently Funded Projects.

Steffen Pabel, University Hospital Regensburg

First application "The functional and molecular mechanisms of tachycardia-induced cardiomyopathy" (2019)

A brief description can be found on our website in the menu Currently Funded Projects.

Kerstin Sarter-Zeiss, University Hospital Erlangen

First application "Butyrophilins, new co-stimulatory molecules, and their role on innate lymphoid cells" (2019)

Julia Schipke, Hannover Medical School

First application "Differentielle Effekte von zucker- und fettinduziertem Übergewicht auf Hypoxie-assoziierte Schäden der Lunge sowie ihre Modulierung durch den körpereigenen Stoff Spermidi" (2019)

Here you can get further information.

A brief description can be found on our website in the menu Currently Funded Projects.

Constanze Schmidt, University Hospital Heidelberg

First application "New treatment strategy for atrial fibrillation and atrial arrhythmias using atrial tattooing" (2019)

Here you can get further information.

A brief description can be found on our website in the menu Currently Funded Projects.

Ria Schönauer, University Hospital Leipzig

First application "From rare to common - investigating universal mechanisms of renal degeneration exemplified by defective MAPKBP1"

Here you can get further information.

A brief description can be found on our website in the menu Currently Funded Projects.

Sebastian Strauss, University Hospital Greifswald

First application "Basics of the Complex Regional Pain Syndrome (CRPS) and its modulation by innovative therapeutic strategies" (2019)

Here you can get further information.

A brief description can be found on our website in the menu Currently Funded Projects.

Franziska Thaler, University Hospital Munich

First application "B-cell-mediated immune response in GAD-antibody associated neurological diseases" (2019)

Here you can get further information.

A brief description can be found on our website in the menu Currently Funded Projects.

Joanne Trinh, University Hospital Lübeck

First application "Investigation of age-at-onset genetic modifier loci in LRRK2 parkinsonism" (2019)

Dr. Markus Waitz, University Hospital Gießen

First application "Use of two different CPAP levels for initial care and therapy of respiratory distress syndrome in very small premature infants - a randomized multicenter study" (2019)

Here you can get further information.

A brief description can be found on our website in the menu Currently Funded Projects.

 

Dennis Wolf, University Hospital Freiburg

First application "CD40L-dependent leukocyte adhesion – a novel target in myocardial infarction" (2019)

Here you can get further information.

A brief description can be found on our website in the menu Currently Funded Projects.

Hans Zempel, University Hospital Cologne

First application "Tau-based therapeutic interventions in models of Alzheimer Disease and related tauophathies" (2019)

Sandra Schlegl, University Hospital Munich

irst application, "Efficacy of a therapist-guided smartphone-based intervention to support recovery from bulimia nervosa: a randomized controlled trial (SMART-BN trial)" (2020)

A brief description can be found on our website in the menu Currently Funded Project.

Christian Schwartz, University Hospital Erlangen

First application, "Bacteria-induced changes to PD-L1:PD-1-mediated interaction between antigen-presenting cells and CD4 T cell subsets" (2019)

 

Jonas-Frederic Sauer, University Hospital Freiburg

First application, "Molecular mechanisms of genetic predisposition to major depressive disorder" (2020)

Here you can get further informaiton.

A brief description can be found on our website in the menu Currently Funded Projects.

Charlotte Flüh , University Hospital Schleswig-Holstein

First application, "Does sex have an influence on glioma growth and is this due to the intrinsic properties of the glioma cells or the tissue environment?" (2020)

Here you can get further information.

A brief description can be found on our website in the menu Currently Funded Projects.

Julia Seyfarth, University Hospital Düsseldorf

First application, "Type 1 Diabetes in Ghana and Germany – Immune pathology of early versus late disease onset and influencing genetic and environmental factors" (2020)

A brief description can be found on our website in the menu Currently Funded Projects.

Julius Fischer, Technical University of Munich

First apllication, "Einfluss kochsalzreicher Ernährung auf radiogenen und immunpathogenen intestinalen Gewebeschaden und die epitheliale Regeneration" (2020)

A brief description can be found on our website in the menu Currently Funded Projects.

Benedikt Schrage, University Hospital Hamburg-Eppendorf

First application, "Predicting myocardial infarction and mortality from digital ECG using neural networks" (2020)

 

Madhuri S. Salker, University Hospital Tübingen

First application, "Deregulation of NFAT5/SGK1 signaling axis contributes to impaired endometrial angiogenesis." (2020)

Here you can get further infornmation.

A brief description can be found on our website in the menu Currently Funded Projects.

Matthias Zielonka, University Hospital Heidelberg

First application, "Identification of new clinical predictive variables and endpoints in patients with urea cycle disorders" (2020)
 

Sergio Guerrero Castillo, University Hospital Hamburg-Eppendorf

First application, "Multiplexed complexomics to foster routine protein complex profiling in medical research and diagnostics"

A brief description can be found on our website in the menu Currently Funded Projects.

Matthias Ilmer, University Hospital Munich

First application, "Intra- and postoperative microbiom in pancreatic carcinoma to determine prognostic factors of postoperative morbidity and tumor recurrence - PancBIOME" (2020)

Here you can get further information.

Alberto Catanese, University Hospital Ulm

First application, "Identify novel convergent pathomechanisms underlying selective death of motoneurons in ALS using patients-derived iPSCs" (2020)

Steffen Daub, University Hospital Mainz

First application, "Studies on the functional significance of cell-specific CD40(L)-mediated activation processes in angiotensin-II-induced hypertension and vascular inflammation" (2020)